99% up by HPLC Azilsartan Medoxomil Potassium 1417576-00-1

Category:Active Pharmaceutical Ingredients > Other Active Pharmaceutical Ingredients
Product Name:99% up by HPLC Azilsartan Medoxomil Potassium 1417576-00-1
CAS No.:1417576-00-1
Standard:ChP
Price(USD):Negotiable
Company:Sinoway Industrial Co.Ltd.

Basic Info
  • Grade: Pharmaceutical Grade

    Factory Location: Xiamen

    Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

  • Monthly Production Capacity: 10tons/year

    Contract Manufacturing: CRO,CMO

    Packaging Information: 25kg/bag

  • Delivery Lead Time: 7 days after payment

    Sample Provided: yes

    Payment Terms: L/C

    Product Information

     

    Product name

    Azilsartan Medoxomil Potassium

    (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-oxo-3-((2’-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-[1,1’-biphenyl]-4-yl)methyl)-2,3-dihydro-1H-benzo[d]imidazole-4-carboxylate

    CAS No.

    1417576-00-1

    Molecular Formula

    C28H20N4O8

    Molecular Weight

    540.489

    Quality Standard

    98% up by HPLC

    Appearance

    White or almost white crystalline powder

     

    COA

     

    ANALYSIS

    SPECIFICATION

    RESULTS

    Appearance

    White or almost white crystalline powder

    White crystalline powder

    Solubility

    Practically insoluble in water

    Conforms

    Identification

    The retention time of the main peak should be consistent with the RS

    Conforms

    The infrared absorption spectrum is concordant with that of RS

    Conforms

    It gives the reaction of potassium(2).

    Positive

    Related substances

    Impurity C  0.15%

    ND

    Impurity A  1.5%

    0.2%

    Unspecified impurities  0.10%

    0.04%

    Total impurities  2.0%

    0.4%

    2-Ethylhexanoic acid

    0. 5%

    0.20%

    Residual solvents

    Ethanol  0.5%

    ND

    Acetone  0.5%

    0.01%

    Dichloromethane  0.06%

    ND

    Tert-Butylmethyl ether  0.5%

    0.10%

    Tetrahydrofuran  0.072%

    ND

    n-Heptane  0.5%

    ND

    Butyl acetate  0.5%

    ND

    Water

     0.5%

    0.09%

    Heavy metals

     20ppm

    Conforms

    Assay

    98.0% - 102.0%(anhydrous substance)

    99.7%

    Conclusion

    The sample complies with the Requirements of In House Specifications.

     

     

     

    Usage

     

     

    Compared to traditional sartan antihypertensive drugs, Azilsartan Medoxomil Potassium, with its unique oxadiazole ring structure, exhibits an affinity for angiotensin II receptors that is increased by over 10,000 times. Additionally, it binds more tightly to the receptor and dissociates more slowly, thereby exerting a potent, stable, and long-lasting antihypertensive effect. Furthermore, Azilsartan Medoxomil Potassium contains a unique pH modifier, which makes it unaffected by gastric acid upon oral administration, effectively enhancing drug stability and solubility.

    While effectively controlling blood pressure, Azilsartan Medoxomil Potassium also offers cardiovascular and renal protective effects. Clinical studies have shown that, in addition to having significantly better antihypertensive efficacy than valsartan and olmesartan, Azilsartan Medoxomil Potassium also outperforms valsartan and olmesartan in reversing cardiac hypertrophy, stabilizing atherosclerotic plaques, resisting myocardial fibrosis, improving insulin resistance, reducing urine protein, and protecting the kidneys.

     

Send your message to this supplier
  • From:
  • To:
    Sinoway Industrial Co.Ltd.
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service